Amoxicillin trihydrate

Art.No : A-030

Formula :

C16H19N3O5S

Conc (% w/w) : 10.0% pet

Molality (% w/w) : -

CAS : 26787-78-0

Series :

Description

[2S-[2alpha,5alpha,6beta(S*)]]-6-[[2-amino-2-(4-hydroxyphenyl) acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; p-Hydroxyampicillin; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo, D-; 6-; (-)-6-[2-amino-2-(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(p-Hydroxy-alpha-aminophenylacetamido) pencillanic acid; 6-(p-hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-[D(-)-alpha-amino-p-hydroxyphenylacetamido]penicillanic acid; alpha-amino-p-hydroxybenzyl penicillin; Alphacin; Agram (Trihydrate); Alfamox; Almodan; Amocilline; Amoclen; Amodex (Trihydrate); Amolin; Amopen; Amopenixin; Alphamox; Amoxi; Amoxidin (Trihydrate); Amoxibiotic (Trihydrate); Amoxicilline; Amoxicillin trihydrate; Amoxidal (Trihydrate); Amoxil; Amoxil (Trihydrate); Amoxillat (Trihydrate); Amoxipen; Amoxi-Wolff (Trihydrate); Amoxycillin; Amoxypen (Trihydrate); AMPC; Anemolin; Aspenil; Augmentin; Betamox; Bristamox; Cabermox; Cemoxin; Cilamox; Clamoxyl; Clamoxyl (Trihydrate); Cuxacillin; D-(-)-alpha-amino-p-hydroxybenzyl penicillin trihydrate; Delacillin; Efpenix; Fisamox; Grinsil; Histocillin; Ibiamox; Imacillin; Larotid; Moxacin; Optium; Ospamox; Piramox; Polymox; Sawacillin; Sawacillin (Trihydrate); Simoxil; Sumox; Trimox; Trimox (Trihydrate); Utimox; Wymox (Trihydrate);

Uses

Amoxicillin or amoxycillin is a moderate-spectrum beta-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other beta-lactam antibiotics. Amoxicillin is susceptible to degradation by beta-lactamase-producing bacteria, and so may be given with clavulanic acid to decrease its susceptibility. It was developed by Beecham in 1972 and is currently marketed by GlaxoSmithKline (the inheritor company) under the original trade name Amoxil.

Menu